AxoGen Company

Axogen is the leading company focused specifically on the science, development and commercialization of technologies for peripheral nerve regeneration and repair.

Technology: Other
Total Funding: $515.5M
Headquarters: United States
Investors Number: 8
Last Funding Type: Series G
Estimated Revenue: $10M to $50M
Industry: Genomic and Epigenominc Instabillity